Xiaowei Qi

565 total citations
16 papers, 354 citations indexed

About

Xiaowei Qi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiaowei Qi has authored 16 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Xiaowei Qi's work include MicroRNA in disease regulation (3 papers), Glycosylation and Glycoproteins Research (1 paper) and Extracellular vesicles in disease (1 paper). Xiaowei Qi is often cited by papers focused on MicroRNA in disease regulation (3 papers), Glycosylation and Glycoproteins Research (1 paper) and Extracellular vesicles in disease (1 paper). Xiaowei Qi collaborates with scholars based in China, United Kingdom and Hong Kong. Xiaowei Qi's co-authors include Bojian Fei, Surui Yao, Zhaohui Huang, Zehua Bian, Yan Qin, Leyuan Zhou, Jian Zou, Yuyang Feng, Jiwei Zhang and Min Li and has published in prestigious journals such as Clinical Cancer Research, Frontiers in Immunology and Medicine.

In The Last Decade

Xiaowei Qi

13 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaowei Qi China	7	185	138	122	101	37	16	354
Weilong Chen China	9	246 1.3×	197 1.4×	127 1.0×	118 1.2×	53 1.4×	14	436
Charles Pallangyo Germany	4	126 0.7×	199 1.4×	84 0.7×	102 1.0×	24 0.6×	5	290
Denis I. Trufa Germany	13	155 0.8×	174 1.3×	190 1.6×	76 0.8×	63 1.7×	21	421
Ilija Crnčec Austria	4	219 1.2×	177 1.3×	66 0.5×	132 1.3×	44 1.2×	4	372
Keith Wells United States	7	184 1.0×	187 1.4×	73 0.6×	57 0.6×	36 1.0×	11	364
Pengfei Sun China	13	178 1.0×	73 0.5×	70 0.6×	108 1.1×	40 1.1×	24	328
Xiangbin Wu China	6	146 0.8×	120 0.9×	64 0.5×	105 1.0×	25 0.7×	9	287
Suli Dai China	12	291 1.6×	82 0.6×	93 0.8×	183 1.8×	41 1.1×	28	413
Shunfeng Hu China	10	184 1.0×	90 0.7×	83 0.7×	81 0.8×	46 1.2×	39	332
Natasha Di Costanzo Australia	6	136 0.7×	156 1.1×	140 1.1×	54 0.5×	76 2.1×	6	337

Countries citing papers authored by Xiaowei Qi

Since Specialization

Citations

This map shows the geographic impact of Xiaowei Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowei Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowei Qi more than expected).

Fields of papers citing papers by Xiaowei Qi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaowei Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowei Qi. The network helps show where Xiaowei Qi may publish in the future.

Co-authorship network of co-authors of Xiaowei Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaowei Qi. A scholar is included among the top collaborators of Xiaowei Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaowei Qi. Xiaowei Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Qian, Jin, Yuxin Wang, Xiaoyan Zhu, et al.. (2025). Platelet-rich plasma-derived exosomes establishing a muscular proregenerative microenvironment through enhancing the viability of fibro-adipogenic progenitors. Experimental & Molecular Medicine. 57(12). 2957–2971.

Luo, Yunbo, Yali Wang, Peng Qu, et al.. (2025). A select inhibitor of MORC2 encapsulated by chimeric membranecoated DNA nanocage target alleviation TNBC progression. Materials Today Bio. 31. 101497–101497.

Zhao, Min, et al.. (2024). Application and prospect of organoid technology in breast cancer. Frontiers in Immunology. 15. 1413858–1413858. 1 indexed citations

Wang, Fang, Qian Wang, Zebo Huang, et al.. (2024). CircMVP promotes METTL3 activation mediated CTNNB1 m6A modification in the inhibition of colorectal cancer in B7-H3 dependence antitumor immunity. International Journal of Biological Sciences. 21(1). 306–327. 4 indexed citations

Huang, Lixue, Xiaoying Gu, Yeming Wang, et al.. (2024). Procalcitonin-guided use of antibiotic in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: a randomized clinical trial. Clinical Microbiology and Infection. 31(5). 785–792. 2 indexed citations

Mi, Yuanyuan, Lifeng Zhang, Chuanyu Sun, et al.. (2022). Lysine demethylase 5A promotes prostate adenocarcinoma progression by suppressing microRNA-330-3p expression and activating the COPB2/PI3K/AKT axis in an ETS1-dependent manner. Journal of Cell Communication and Signaling. 16(4). 579–599. 5 indexed citations

Han, Shuang, et al.. (2022). Development of a Chemiluminescence Assay for Total N‐Terminal Propeptide of Type I Collagen and Its Evaluation in Lung Transplantation. Journal of Analytical Methods in Chemistry. 2022(1). 2711414–2711414. 1 indexed citations

Qin, Yan, et al.. (2019). Efficacy and adverse reactions of combination therapy of bevacizumab and 5-fluorouracil in patients with metastatic colon cancer.. PubMed. 24(2). 494–500. 1 indexed citations

Lu, Tingxun, Shuang Wu, Ying Zhang, et al.. (2019). CD5+MYC+ predicts worse prognosis in diffuse large B-cell lymphoma. Experimental and Molecular Pathology. 112. 104326–104326. 4 indexed citations

10.

Jiang, Hui, et al.. (2019). A 21‑gene Support Vector Machine classifier and a 10‑gene risk score system constructed for patients with gastric cancer. Molecular Medicine Reports. 21(1). 347–359. 21 indexed citations

11.

Wang, Zhiqiang, et al.. (2018). Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. Medicine. 97(52). e13806–e13806. 9 indexed citations

12.

Jin, Lei, et al.. (2018). Immunohistochemical analysis and comparison of napsin A, TTF1, SPA and CK7 expression in primary lung adenocarcinoma. Biotechnic & Histochemistry. 93(5). 364–372. 8 indexed citations

13.

Yin, Yuan, Surui Yao, Yaling Hu, et al.. (2017). The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-Derived IL6. Clinical Cancer Research. 23(23). 7375–7387. 208 indexed citations

14.

Chen, Zhen, Chunlei Tang, Mingxu Xie, et al.. (2016). TrpC5 regulates differentiation through the Ca2+/Wnt5a signalling pathway in colorectal cancer. Clinical Science. 131(3). 227–237. 28 indexed citations

15.

Chen, Yun, Yifei Zhu, Zhen Chen, et al.. (2015). Breast cancer resistance protein (BCRP)-containing circulating microvesicles contribute to chemoresistance in breast cancer. Oncology Letters. 10(6). 3742–3748. 40 indexed citations

16.

Chen, Junliang, Dai Li, Peng Zhang, et al.. (2015). Methylene blue attenuates acute liver injury induced by paraquat in rats. International Immunopharmacology. 28(1). 808–812. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact